Multidimensional digital histopathology using scalable optical micro-chip technologies

with Christopher Andrew Dirdal, Research Manager og Senior Scientist, SINTEF

Diagnosing diseases such as cancer, infections, and autoimmune disorders often relies on time-consuming and partly subjective analyses of tissue samples. At Driving Health Tech 2026, Christopher Dirdal presented a new technological breakthrough in which optical microchip technologies and machine learning enable rapid, objective, and three-dimensional analysis of tissue—entirely without traditional sample preparation—with the potential to improve both diagnostic accuracy and clinical decision-making.   

About the Speaker  

Christopher Dirdal is Research Manager of the Micro Optics research group at SINTEF Digital, wherehe works with chip-based optical sensor technologies, including nanophotonics, MOEMS, and integrated waveguide platforms. He is affiliated with SINTEF MiNaLab, a national research infrastructure for micro- and nanotechnology that has served as a foundation for several successful medtech startups in diagnostics and monitoring.  

About Driving Health Tech  

This recording is from Driving Health Tech 2026, held on 4 February in Copenhagen.  

Driving Health Tech is IDA’s annual flagship conference in health technology, bringing together the latest solutions, ideas, and technological breakthroughs to address the healthcare system’s most complex challenges and help shape the future of healthcare.  

Want to join next time?  

Sign up for IDA Sundhedsteknologi | Sundhedsfagligt netværk and receive notifications about upcoming events and conferences.